share_log

和鉑醫藥-B：翌日披露報表

HBM HOLDINGS-B: Next Day Disclosure Return

Hong Kong Stock Exchange ·  Apr 18 06:30
Summary by Moomoo AI
和鉑醫藥控股有限公司（和铂医药-B）於2024年4月18日提交了翌日披露報表，披露其已發行股本出現變動。根據報表，公司於2024年4月2日的已發行股本為770,142,410股，而在2024年4月18日，公司通過股份獎勵計劃發行了98,000股普通股，使得結存的已發行股本增至770,240,410股。該次股份發行的發行價為每股HKD 0，相較於上一個營業日每股收市價HKD 1.09，折讓幅度為100%。公司確認，所有相關的法律及上市規定已遵守，並且所有應得款項已收取，所有交易已完成。
和鉑醫藥控股有限公司（和铂医药-B）於2024年4月18日提交了翌日披露報表，披露其已發行股本出現變動。根據報表，公司於2024年4月2日的已發行股本為770,142,410股，而在2024年4月18日，公司通過股份獎勵計劃發行了98,000股普通股，使得結存的已發行股本增至770,240,410股。該次股份發行的發行價為每股HKD 0，相較於上一個營業日每股收市價HKD 1.09，折讓幅度為100%。公司確認，所有相關的法律及上市規定已遵守，並且所有應得款項已收取，所有交易已完成。
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (PLATINUM PHARMACEUTICALS-B) FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 18, 2024 DISCLOSING THE CHANGE IN ITS ISSUED SHARE CAPITAL. According to the report, the issued share capital of the company on April 2, 2024 was 770,142,410 shares, and on April 18, 2024, the company issued 98,000 shares of ordinary shares through the share bonus scheme, increasing the issued share capital to 770,240,410 shares. The issue price of this share is HKD 0 per share, representing a margin of 100% compared to the closing price of HKD 1.09 per share on the previous business day. The Company confirms that all relevant laws and listing requirements have been complied with and that all monies due have been received and all transactions have been completed.
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (PLATINUM PHARMACEUTICALS-B) FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 18, 2024 DISCLOSING THE CHANGE IN ITS ISSUED SHARE CAPITAL. According to the report, the issued share capital of the company on April 2, 2024 was 770,142,410 shares, and on April 18, 2024, the company issued 98,000 shares of ordinary shares through the share bonus scheme, increasing the issued share capital to 770,240,410 shares. The issue price of this share is HKD 0 per share, representing a margin of 100% compared to the closing price of HKD 1.09 per share on the previous business day. The Company confirms that all relevant laws and listing requirements have been complied with and that all monies due have been received and all transactions have been completed.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more